Eric Lefkofsky is an entrepreneur, and one of his successful ventures is Tempus Labs. Tempus Labs has developed a molecular and clinical library of digitized genomic and patient information designed to provide physicians with a searchable database of DNA and clinical data so they can individualize care for cancer patients. The data is available to physicians in real time so they can make data-driven decisions to benefit each patient.
Tempus Labs is a privately held company with more than 11,000 employees in 48 countries. The company is still growing thanks to an infusion of cash from investors. According to a recent Chicago Tribune article, Tempus Labs recently received more than $80 million in additional funding. New investors like Kinship Trust Co. and T. Rowe Price Associates have joined long-time supporters like New Enterprise Associates and Revolution Growth. This infusion of cash not only increased total investments in Tempus Labs to more than $210 million but it simultaneously boosted the valuation of Tempus Labs to more than $1 billion.
Startups with a valuation of more than $1 billion are rare, so rare in fact, it led Aileen Lee a venture capitalist, to dub such startups as “a unicorn.” More than 50 percent of startups fail within the first four years, so the success of Eric Lefkofsky and Tempus Labs make them unique. As a biotech firm, Tempus Labs has successfully merged healthcare and technology. In an article written by Lefkofsky, he stated, “Healthcare, as an industry, is ripe for technological disruption. The potential for positive impact, particularly in the area of cancer care is both enormous and imminent.”
Tempus Labs and Eric Lefkofsky are in the forefront of healthcare research by leading a group of scientists, researchers, and physicians to develop cutting-edge tools to individualize health care. The mission of Tempus Labs is “to enhance the quality of human lives.” The continued success of Eric Lefkofsky and Tempus Labs indicate they are living up to their mission. Through genomic sequencing and mapping, Tempus Labs is in the forefront of revolutionizing cancer care.
To know more visit @: www.tempus.com/about-us/